Biofrontera Inc. (BFRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Zacks Investment Research • 11/22/23
Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business UpdateAccesswire • 11/09/23
Biofrontera Inc. (BFRI) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 11/09/23
Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10Accesswire • 11/03/23
Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ RulesAccesswire • 10/31/23
Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology ConferenceAccesswire • 10/05/23
All You Need to Know About Biofrontera Inc. (BFRI) Rating Upgrade to BuyZacks Investment Research • 09/18/23
Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer AccountsAccesswire • 08/29/23
Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R)Accesswire • 08/28/23
Biofrontera Inc. Reports Second Quarter 2023 Financial Results and Provides a Business UpdateAccesswire • 08/11/23
Biofrontera Inc. Announces Last Patient Enrolled in Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Basal Cell CarcinomaAccesswire • 08/10/23
Biofrontera Inc. Announces Preliminary Second Quarter Revenues are Up 26% to 31%Accesswire • 07/13/23
Biofrontera Inc. Sponsors The Sun Bus, Delivering Free Mobile Skin Cancer Screenings Across the U.S.Accesswire • 06/12/23
Biofrontera Inc. Begins Development of a Portable Photodynamic Therapy Lamp for Use with Ameluz(R)-PDTAccesswire • 06/01/23
Biofrontera Inc. Names Founder and Executive Chairman Hermann Luebbert as Chief Executive OfficerAccesswire • 05/30/23
Biofrontera Inc. Announces U.S. Patent Issued for Photodynamic Therapy Protocol with Reduced Side EffectsAccesswire • 05/15/23